PG13 Asthma: pathology and treatment

Postgraduate Course
Chairs: G. Joos (Gent, Belgium), G. Canonica (Genoa, Italy)
Aims: There is a need to discuss the evolving scientific knowledge describing pathogenesis relating to environmental factors, inflammation, infection, and their interaction with genetic predisposition. In addition, the current concepts in disease heterogeneity and impact must be examined including pathophysiology, and the role of systemic manifestations of disease. Finally, these concepts must be linked to rapidly evolving notions regarding therapy.

HERMES syllabus links: A.1: Structure and function of the respiratory system; A.1.4: Pathophysiology; A.1.7: Pharmacology; A.1.9: Immunology and defense mechanisms; B.1: Airway diseases; B.1.1: Asthma; B.17: Allergic diseases (IgE-mediated); B.17.1: Upper airway disease; B.17.2: Asthma; E.1.1; Systemic inhaled drug therapy.
Type of course: Lecture based
Level: Intermediate

Complexity of inflammation in asthma J. Lotvall (Gothenburg, Sweden)
Mechanisms of bronchial hyperresponsiveness in asthma D. Spina (London, United Kingdom)
Airflow limitation in the nose and lungs R. Dahl (Aarhus, Denmark)
Targeting airway inflammation in asthma: current and future therapies N. Hanania (Houston, Tx, United States of America)